These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A clinical trial of nifedipine in schizophrenia and tardive dyskinesia.
    Author: Suddath RL, Straw GM, Freed WJ, Bigelow LB, Kirch DG, Wyatt RJ.
    Journal: Pharmacol Biochem Behav; 1991 Jul; 39(3):743-5. PubMed ID: 1686106.
    Abstract:
    Effects of the dihydropyridine calcium channel inhibitor nifedipine on chronic schizophrenia and tardive dyskinesia were studied in an 8-week double-blind crossover trial. Four of the ten patients had tardive dyskinesia, and three of these were not receiving neuroleptics. No effects on symptoms of chronic schizophrenia were found using Psychiatric Symptom Assessment Scale ratings. In the four patients with tardive dyskinesia, an average improvement in total Abnormal Involuntary Movement Scale scores of 57% was observed. These data suggest that dihydropyridine calcium channel inhibitors may be effective in the treatment of tardive dyskinesia in schizophrenic patients.
    [Abstract] [Full Text] [Related] [New Search]